Cargando…

Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates

BACKGROUND: Cardiac resynchronisation therapy (CRT) is increasingly used in children in a variety of anatomical and pathophysiological conditions, but published data are scarce. OBJECTIVE: To record current practice and results of CRT in paediatric and congenital heart disease. DESIGN: Retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janoušek, J, Gebauer, R A, Abdul-Khaliq, H, Turner, M, Kornyei, L, Grollmuß, O, Rosenthal, E, Villain, E, Früh, A, Paul, T, Blom, N A, Happonen, J-M, Bauersfeld, U, Jacobsen, J R, van den Heuvel, F, Delhaas, T, Papagiannis, J, Trigo, C
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2009
Materias:	Heart failure and cardiomyopathy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699215/ https://www.ncbi.nlm.nih.gov/pubmed/19307198 http://dx.doi.org/10.1136/hrt.2008.160465

Ejemplares similares

Measures of endothelial dysfunction predict response to cardiac resynchronisation therapy
por: Warriner, David R, et al.
Publicado: (2016)

Scar burden is an independent and incremental predictor of cardiac resynchronisation therapy response
por: Harb, Serge C, et al.
Publicado: (2019)

Does recovery from submaximal exercise predict response to cardiac resynchronisation therapy?
por: Wouters, Philippe, et al.
Publicado: (2022)

Prognostic importance of the Controlling Nutritional Status (CONUT) score in patients undergoing cardiac resynchronisation therapy
por: Ikeya, Yukitoshi, et al.
Publicado: (2021)

Characterisation of circulating biomarkers before and after cardiac resynchronisation therapy and their role in predicting CRT response: the COVERT-HF study
por: McAloon, Christopher J, et al.
Publicado: (2018)

Mechanical dyssynchrony is additive to ECG criteria and independently associated with reverse remodelling and clinical response to cardiac resynchronisation therapy in patients with advanced heart failure
por: Bank, Alan J, et al.
Publicado: (2015)

Determinants of LV dP/dt(max) and QRS duration with different fusion strategies in cardiac resynchronisation therapy
por: Odland, Hans Henrik, et al.
Publicado: (2021)

Extracellular cardiac matrix biomarkers in patients with reduced ejection fraction heart failure as predictors of response to cardiac resynchronisation therapy: a systematic review
por: McAloon, Christopher J, et al.
Publicado: (2017)

Outcomes of cardiac resynchronisation therapy in patients with heart failure with atrial fibrillation: a systematic review and meta-analysis of observational studies
por: Mustafa, Usman, et al.
Publicado: (2019)

Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function
por: Medenwald, D, et al.
Publicado: (2014)

Smoking intensity and duration is associated with cardiac structure and function: the ECHOcardiographic Study of Hispanics/Latinos
por: Leigh, J Adam, et al.
Publicado: (2017)

Individual patient data network meta-analysis of mortality effects of implantable cardiac devices
por: Woods, B, et al.
Publicado: (2015)

What can we learn from RELAX-AHF compared to previous AHF trials and what does the future hold?
por: Cannon, Jane A, et al.
Publicado: (2015)

Higher number of live births is associated with left ventricular diastolic dysfunction and adverse cardiac remodelling among US Hispanic/Latina women: results from the Echocardiographic Study of Latinos
por: Aggarwal, Shivani R, et al.
Publicado: (2017)

Catheter ablation and mortality, stroke and heart failure readmission with atrial fibrillation
por: Pallisgaard, Jannik Langtved, et al.
Publicado: (2020)

Relationships among achieved heart rate, β-blocker dose and long-term outcomes in patients with heart failure with atrial fibrillation
por: Miller, Robert J H, et al.
Publicado: (2016)

Calibrated integrated backscatter and myocardial fibrosis in patients undergoing cardiac surgery
por: Prior, David L, et al.
Publicado: (2015)

Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy
por: Hammersley, Daniel J, et al.
Publicado: (2022)

Asymptomatic left ventricular dysfunction with long-term clozapine treatment for schizophrenia: a multicentre cross-sectional cohort study
por: Chow, V, et al.
Publicado: (2014)

Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy
por: Law, Steven, et al.
Publicado: (2022)

Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy
por: Sugrue, Alan, et al.
Publicado: (2017)

Prospective development and validation of a model to predict heart failure hospitalisation
por: Cubbon, R M, et al.
Publicado: (2014)

Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification
por: Cubbon, Richard M, et al.
Publicado: (2016)

Stress-coping skills and neuroticism in apical ballooning syndrome (Takotsubo/stress cardiomyopathy)
por: Scantlebury, Dawn C, et al.
Publicado: (2016)

Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy
por: Wasielewski, Marijke, et al.
Publicado: (2014)

Socioeconomic deprivation and mode-specific outcomes in patients with chronic heart failure
por: Witte, Klaus K, et al.
Publicado: (2018)

Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure
por: Cubbon, Richard M, et al.
Publicado: (2016)

Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2022)

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
por: Lee, Dawn, et al.
Publicado: (2014)

Iron deficiency in 78 805 people admitted with heart failure across England: a retrospective cohort study
por: Beattie, James M, et al.
Publicado: (2020)

CLINICAL CHARACTERISTICS, OUTCOMES AND IMMUNOSUPPRESSION STRATEGIES OF HEART TRANSPLANT RECIPIENTS INFECTED WITH COVID-19
por: Ilonze, Onyedika J., et al.
Publicado: (2021)

Rationale and design of the preserved versus reduced ejection fraction biomarker registry and precision medicine database for ambulatory patients with heart failure (PREFER-HF) study
por: Abboud, Andrew, et al.
Publicado: (2021)

Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis
por: Stirrat, Colin G, et al.
Publicado: (2018)

Progressive left ventricular dysfunction and long-term outcomes in patients with Duchenne muscular dystrophy receiving cardiopulmonary therapies
por: Wang, Mary, et al.
Publicado: (2018)

Systematic review and meta-analysis of prolactin and iron deficiency in peripartum cardiomyopathy
por: Cherubin, Sinaida, et al.
Publicado: (2020)

A Score to differentiate Takotsubo syndrome from non-ST-elevation myocardial nfarction in women at the bedside
por: Looi, Jen-Li, et al.
Publicado: (2020)

Association of heart failure and its comorbidities with loss of life expectancy
por: Drozd, Michael, et al.
Publicado: (2021)

Lamin mutation location predicts cardiac phenotype severity: combined analysis of the published literature
por: Captur, Gabriella, et al.
Publicado: (2018)

Update in imaging of cancer therapy-related cardiac toxicity in adults
por: de Baat, Esmée C, et al.
Publicado: (2021)

MRI and CT coronary angiography in survivors of COVID-19
por: Singh, Trisha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sov78rdllshpoe2dd1fphhpu16